Bristol Increases Reserves In Anticipation Of Further SEC Action
This article was originally published in The Pink Sheet Daily
Executive Summary
The company has set aside $140 mil. as its minimum estimated liability from ongoing investigations into accounting issues. Bristol already paid $150 mil. to settle civil claims filed by SEC.
You may also be interested in...
Bristol Agrees To Continue Improving Financial Controls In Settling Shareholder Lawsuit
As part of proposed settlement of a derivative lawsuit, the company will continue to develop and implement oversight and disclosure policies that resulted from a 2004 settlement with SEC.
Bristol Agrees To One-Month Inventory Limit Under SEC Settlement
Settlement marks first definition of "normal" inventory levels for pharmaceutical industry. Bristol agrees to $150 mil. civil penalty to resolve investigation into "channel stuffing" during 2000-2001.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.